A Florida-focused TV commercial that captures the profound nature of a cancer patient’s journey was recognized with top honors among more than 6,500 entries from around the globe in the 2022 Hermes Creative Awards.
Florida Cancer Specialists & Research Institute, LLC (FCS) held a ribbon-cutting ceremony on August 18, 2022 to celebrate the opening of its newest clinical site in Pasco County.
Chief Medical Officer of Therapeutics and Analytics Lucio Gordan, MD, has made a habit of distributing top articles to Florida Cancer Specialists clinicians on a monthly basis, sharing relevant articles and studies as they become available in the oncology and hematology world.
Working collaboratively with Florida Cancer Specialists & Research Institute, LLC (FCS), NCODA, Inc. developed a more efficient way for healthcare professionals to expand their knowledge and share feedback about ongoing advancements.
Physicians from around the country are learning advanced surgical techniques from a Florida Cancer Specialists gynecologic oncologist who is skilled at using the da Vinci® robotic-assisted surgical system. Jessica Stine, MD, who provides care at FCS Trinity and Wesley Chapel locations has received designation as a National GYN Oncology Observation Site for Intuitive Surgical.
An in-depth article authored by Florida Cancer Specialists & Research Institute, LLC (FCS) pharmacy experts published in the American Journal of Managed Care® (AJMC®) issues a call to action for the development of improved metrics to help lower costs and better assess the performance of pharmacies that dispense oral oncolytic medications.
FCS Top News Updates
FCS Contributing To Breakthroughs In Treatment of Blood Cancers & Disorders
Florida Cancer Specialists & Research Institute Receives Top Recognition from International Creative Awards OrganizationA Florida-focused TV commercial that captures the profound nature of a cancer patient’s journey was recognized with top honors among more than 6,500 entries from around the globe in the 2022 Hermes Creative Awards.
FCS Celebrates Addition of Next Generation Genomic TestingGrand Opening of FCS laboratory in Fort Myers, expands the FCS genomic testing capabilities to include Next Generation Sequencing.
Florida Cancer Specialists & Research Institute Appoints New Members to Senior ManagementFlorida Cancer Specialists & Research Institute (FCS) is pleased to welcome new members to its senior management team.
FCS Opens Sixth Clinic Location in Pasco CountyFlorida Cancer Specialists & Research Institute, LLC (FCS) held a ribbon-cutting ceremony on August 18, 2022 to celebrate the opening of its newest clinical site in Pasco County.
FCS Hematology Oncology ReviewChief Medical Officer of Therapeutics and Analytics Lucio Gordan, MD, has made a habit of distributing top articles to Florida Cancer Specialists clinicians on a monthly basis, sharing relevant articles and studies as they become available in the oncology and hematology world.
NCODA and FCS Announce New Oncology Stakeholder Education Exchange ProgramWorking collaboratively with Florida Cancer Specialists & Research Institute, LLC (FCS), NCODA, Inc. developed a more efficient way for healthcare professionals to expand their knowledge and share feedback about ongoing advancements.
FCS Gynecologic OncologistsPhysicians from around the country are learning advanced surgical techniques from a Florida Cancer Specialists gynecologic oncologist who is skilled at using the da Vinci® robotic-assisted surgical system. Jessica Stine, MD, who provides care at FCS Trinity and Wesley Chapel locations has received designation as a National GYN Oncology Observation Site for Intuitive Surgical.
FCS Defines Optimal Performance Metrics for Pharmacies Dispensing Oral Oncology MedicationsAn in-depth article authored by Florida Cancer Specialists & Research Institute, LLC (FCS) pharmacy experts published in the American Journal of Managed Care® (AJMC®) issues a call to action for the development of improved metrics to help lower costs and better assess the performance of pharmacies that dispense oral oncolytic medications.